67 related articles for article (PubMed ID: 28511498)
21. Molecular diagnostics in oral cancer and oral potentially malignant disorders-A clinician's guide.
Yap T; Celentano A; Seers C; McCullough MJ; Farah CS
J Oral Pathol Med; 2020 Jan; 49(1):1-8. PubMed ID: 31309636
[TBL] [Abstract][Full Text] [Related]
22. Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory.
Dionne KR; Warnakulasuriya S; Zain RB; Cheong SC
Int J Cancer; 2015 Feb; 136(3):503-15. PubMed ID: 24482244
[TBL] [Abstract][Full Text] [Related]
23. Antioxidant-Oxidant Index as a Biomarker in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma: A Biochemical Study.
Juneja S; Rathore AS; Sharma K; Shetty D; Jain A
J Clin Diagn Res; 2017 Mar; 11(3):ZC05-ZC08. PubMed ID: 28511498
[TBL] [Abstract][Full Text] [Related]
24. Assessment of serum synuclein-γ and squamous cell carcinoma antigen as diagnostic biomarkers in patients with oral squamous cell carcinoma and oral potentially malignant disorders.
Chen L; Luo T; Yang J; Wang K; Liu S; Wei Y; Liu H; Xu J; Zheng J; Zeng Y
J Oral Pathol Med; 2021 Feb; 50(2):165-174. PubMed ID: 33064859
[TBL] [Abstract][Full Text] [Related]
25. Serum and Saliva LDH Levels in Patients with Habit, Oral Potentially Malignant Disorders (OPMDs), and Oral Squamous Cell Carcinoma (OSCC): A Spectrophotometry Study.
Shah FY; Shetty DC; Kaur G; Gupta S; Pathak A; Aggarwal V
J Pharm Bioallied Sci; 2023 Jul; 15(Suppl 2):S881-S884. PubMed ID: 37694076
[TBL] [Abstract][Full Text] [Related]
26. Oxidant-antioxidant status in blood and tumor tissue of oral squamous cell carcinoma patients.
Gokul S; Patil VS; Jailkhani R; Hallikeri K; Kattappagari KK
Oral Dis; 2010 Jan; 16(1):29-33. PubMed ID: 19656315
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of Proinflammatory, NF-kappaB Dependent Cytokines: IL-1α, IL-6, IL-8, and TNF-α in Tissue Specimens and Saliva of Patients with Oral Squamous Cell Carcinoma and Oral Potentially Malignant Disorders.
Babiuch K; Kuśnierz-Cabala B; Kęsek B; Okoń K; Darczuk D; Chomyszyn-Gajewska M
J Clin Med; 2020 Mar; 9(3):. PubMed ID: 32245251
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of Mast Cells in Oral Potentially Malignant Disorders and Oral Squamous Cell Carcinoma.
Shrestha A; Keshwar S; Raut T
Int J Dent; 2021; 2021():5609563. PubMed ID: 34490052
[TBL] [Abstract][Full Text] [Related]
29. The Expression and Correlation of iNOS and p53 in Oral Squamous Cell Carcinoma.
Yang L; Wang Y; Guo L; Wang L; Chen W; Shi B
Biomed Res Int; 2015; 2015():637853. PubMed ID: 26523280
[TBL] [Abstract][Full Text] [Related]
30. Vitamin and carotenoid intake and risk of head-neck cancer subtypes in the Netherlands Cohort Study.
de Munter L; Maasland DH; van den Brandt PA; Kremer B; Schouten LJ
Am J Clin Nutr; 2015 Aug; 102(2):420-32. PubMed ID: 26156734
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms of pharmacological doses of ascorbate on cancer cells.
Venturelli S; Sinnberg TW; Niessner H; Busch C
Wien Med Wochenschr; 2015 Jun; 165(11-12):251-7. PubMed ID: 26065536
[TBL] [Abstract][Full Text] [Related]
32. Expression of inducible nitric oxide synthase in carcinomas and sarcomas affecting the oral cavity.
Augustine D; Sekar B; Murali S; Ramesh M; Madhavan RN; Patil SG; Rao RS
South Asian J Cancer; 2015; 4(2):78-82. PubMed ID: 25992347
[TBL] [Abstract][Full Text] [Related]
33. Natural vitamin C intake and the risk of head and neck cancer: A pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.
Edefonti V; Hashibe M; Parpinel M; Turati F; Serraino D; Matsuo K; Olshan AF; Zevallos JP; Winn DM; Moysich K; Zhang ZF; Morgenstern H; Levi F; Kelsey K; McClean M; Bosetti C; Galeone C; Schantz S; Yu GP; Boffetta P; Amy Lee YC; Chuang SC; La Vecchia C; Decarli A
Int J Cancer; 2015 Jul; 137(2):448-62. PubMed ID: 25627906
[TBL] [Abstract][Full Text] [Related]
34. Serum vitamin c and iron levels in oral submucous fibrosis.
Guruprasad R; Nair PP; Singh M; Singh M; Singh M; Jain A
Indian J Dent; 2014 Apr; 5(2):81-5. PubMed ID: 25565730
[TBL] [Abstract][Full Text] [Related]
35. Treatment of oral leukoplakia with a low-dose of beta-carotene and vitamin C supplements: a randomized controlled trial.
Nagao T; Warnakulasuriya S; Nakamura T; Kato S; Yamamoto K; Fukano H; Suzuki K; Shimozato K; Hashimoto S
Int J Cancer; 2015 Apr; 136(7):1708-17. PubMed ID: 25156040
[TBL] [Abstract][Full Text] [Related]
36. Do tobacco stimulate the production of nitric oxide by up regulation of inducible nitric oxide synthesis in cancer: Immunohistochemical determination of inducible nitric oxide synthesis in oral squamous cell carcinoma--a comparative study in tobacco habituers and non-habituers.
Karthik B; Shruthi DK; Singh J; Tegginamani AS; Kudva S
J Cancer Res Ther; 2014; 10(2):244-50. PubMed ID: 25022373
[TBL] [Abstract][Full Text] [Related]
37. Oxidative and antioxidative mechanisms in oral cancer and precancer: a review.
Choudhari SK; Chaudhary M; Gadbail AR; Sharma A; Tekade S
Oral Oncol; 2014 Jan; 50(1):10-8. PubMed ID: 24126222
[TBL] [Abstract][Full Text] [Related]
38. The effects of high concentrations of vitamin C on cancer cells.
Park S
Nutrients; 2013 Sep; 5(9):3496-505. PubMed ID: 24022818
[TBL] [Abstract][Full Text] [Related]
39. Nitric oxide and cancer: a review.
Choudhari SK; Chaudhary M; Bagde S; Gadbail AR; Joshi V
World J Surg Oncol; 2013 May; 11():118. PubMed ID: 23718886
[TBL] [Abstract][Full Text] [Related]
40. Ascorbic acid and its pro-oxidant activity as a therapy for tumours of oral cavity -- a systematic review.
Putchala MC; Ramani P; Sherlin HJ; Premkumar P; Natesan A
Arch Oral Biol; 2013 Jun; 58(6):563-74. PubMed ID: 23477602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
